Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | HALO | VKTX | ||
| Company | Blueprint Medicines Corp | Halozyme Therapeutic | Viking Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 96.78 | 48.93 | 53.07 | ||
| High | 98.34 | 49.57 | 53.52 | ||
| Low | 94.11 | 46.21 | 51.95 | ||
| Last | 94.15 | 49.00 | 52.59 | ||
| Change | -2.47 | +3.30 | +0.96 | ||
| % Change | -2.56% | +7.22% | +1.86% | ||
| Volume | 663,500 | 4,549,600 | 2,633,100 | ||
| 20-Day Average Volume | 758,350 | 2,298,815 | 6,187,020 | ||
| Previous Close | 96.62 | 45.70 | 51.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 93.65 | 53.23 | 61.71 | ||
| 20-Day Raw Stochastic | 58.91% | 34.75% | 14.50% | ||
| 20-Day Relative Strength | 52.40% | 43.39% | 40.25% | ||
| Weighted Alpha | +24.68 | +24.93 | +35.28 | ||
| Today's Opinion | 48% Sell | 40% Sell | 40% Sell | ||
| Previous Opinion | 16% Sell | 40% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.16% since 11/15/24 | +7.34% since 11/15/24 | +6.07% since 11/15/24 | ||
| Low | 88.05 on 11/18/24 | 42.01 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 98.34 on 11/22/24 | 49.57 on 11/22/24 | 54.28 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +8.88% since 10/22/24 | -4.95% since 10/22/24 | -15.22% since 10/22/24 | ||
| Low | 80.68 on 10/29/24 | 42.01 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 103.55 on 11/11/24 | 62.13 on 11/11/24 | 81.73 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | +0.68% since 08/22/24 | -20.51% since 08/22/24 | -18.28% since 08/22/24 | ||
| Low | 80.68 on 10/29/24 | 42.01 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 103.55 on 11/11/24 | 65.53 on 08/29/24 | 81.73 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | -8.33% since 05/22/24 | +7.74% since 05/22/24 | -16.54% since 05/22/24 | ||
| Low | 80.68 on 10/29/24 | 42.01 on 11/18/24 | 46.11 on 06/26/24 | ||
| High | 121.90 on 07/16/24 | 65.53 on 08/29/24 | 81.73 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,980,973 | 6,234,123 | 5,860,419 | ||
| Shares Outstanding, K | 63,526 | 127,227 | 111,436 | ||
| Annual Sales | 249,380,000 | 829,250,000 | 0 | ||
| Annual Net Income | -506,980,000 | 281,590,000 | -85,900,000 | ||
| Last Quarter Sales | 128,180,000 | 290,080,000 | 0 | ||
| Last Quarter Net Income | -56,280,000 | 137,010,000 | -24,940,000 | ||
| 60-Month Beta | 0.59 | 1.29 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 10/30/24 | 1.27 on 10/31/24 | -0.22 on 10/23/24 | ||
| Latest Earnings Date | 10/30/24 | 10/31/24 | 10/23/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.13 | 0.00 | ||